Markets:

Overview

News

Currencies

International

Treasuries

Revvity, Inc. Common Stock (NY:RVTY)

154.36 -0.72 (-0.46%)

Delayed Quote Updated: 11:09 AM EDT, Oct 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Revvity, Inc. Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

A Glimpse of Revvity's Earnings Potential ↗

July 25, 2025

Via Benzinga

Revvity Board Declares Quarterly Dividend

July 24, 2025

From Revvity

Via Business Wire

Monday's session: gap up and gap down stock in the S&P500 index ↗

July 21, 2025

Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Monday to uncover the stocks that are gapping in the S&P500 index.

Via Chartmill

Thermo Fisher, Exact Sciences, Integer Holdings, Revvity, and 10x Genomics Shares Are Falling, What You Need To Know

July 18, 2025

A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like...

Via StockStory

Topics Lawsuit World Trade

Peering Into Revvity's Recent Short Interest ↗

June 30, 2025

Via Benzinga

Is the Market Bullish or Bearish on Revvity? ↗

May 21, 2025

Via Benzinga

Reflecting On Research Tools & Consumables Stocks’ Q1 Earnings: Revvity (NYSE:RVTY)

July 13, 2025

Let’s dig into the relative performance of Revvity (NYSE:RVTY) and its peers as we unravel the now-completed Q1 research tools & consumables earnings season.

Via StockStory

Topics Economy

Revvity to Hold Earnings Call on Monday, July 28, 2025

July 07, 2025

From Revvity

Via Business Wire

3 Low-Volatility Stocks in the Doghouse

July 03, 2025

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.

Via StockStory

What 9 Analyst Ratings Have To Say About Revvity ↗

June 26, 2025

Via Benzinga

1 Profitable Stock with Exciting Potential and 2 to Be Wary Of

June 18, 2025

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Via StockStory

3 Healthcare Stocks Skating on Thin Ice

June 04, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of...

Via StockStory

Topics Stocks

Revvity Introduces New IVD Reference Standards for Monitoring Oncology Diagnostic Testing Workflows

June 02, 2025

From Revvity

Via Business Wire

Revvity’s EUROIMMUN Unveils New Fully Automated Instrument for Specialty Testing

May 19, 2025

From Revvity

Via Business Wire

3 Mid-Cap Stocks with Questionable Fundamentals

May 15, 2025

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with...

Via StockStory

Stay informed with the top movers within the S&P500 index on Wednesday. ↗

May 14, 2025

Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Wednesday as we examine the latest happenings in today's session.

Via Chartmill

What's going on in today's session: S&P500 movers ↗

May 14, 2025

Curious about the top performers within the S&P500 index in the middle of the day on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

Via Chartmill

Which S&P500 stocks are gapping on Wednesday? ↗

May 14, 2025

Looking for the S&P500 stocks that are experiencing notable gaps on Wednesday? Find out which stocks are gapping up and gapping down in the S&P500 index during today's session.

Via Chartmill

Repligen, Bruker, Agilent, Medpace, and Revvity Shares Skyrocket, What You Need To Know

May 12, 2025

A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides...

Via StockStory

Topics Government Stocks World Trade

RVTY Q1 Earnings Call: Resilient Performance Amid Academic and Tariff Headwinds, Software and Diagnostics Shine

May 12, 2025

Life sciences company Revvity (NYSE:RVTY) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 2.3% year on year to $664.8 million. The company’s full-year revenue...

Via StockStory

Topics Economy World Trade

3 S&P 500 Stocks in the Doghouse

May 06, 2025

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some...

Via StockStory

Topics Stocks

1 Safe-and-Steady Stock with Exciting Potential and 2 to Avoid

May 01, 2025

Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.

Via StockStory

Revvity to Present at Upcoming Investor Conferences

April 30, 2025

From Revvity

Via Business Wire

What's going on in today's pre-market session: S&P500 movers ↗

April 28, 2025

Stay updated with the S&P500 stocks that are on the move in today's pre-market session.

Via Chartmill

Life Science Tools Maker Revvity Delivers Strong Q1 Earnings Despite Evolving Macroeconomic Backdrop ↗

April 28, 2025

Revvity posts strong Q1 results with Life Sciences and Diagnostics growth, lifts 2025 sales guidance, and expects higher adjusted operating margins.

Via Benzinga

Revvity Q1 Earnings Surpass Street Estimates, Investors Cheer 2025 Revised Revenue Guidance ↗

April 28, 2025

For the full year, Revvity raised its revenue guidance to a range of $2.83 billion to $2.87 billion to reflect recent changes in foreign currency exchange rates.

Via Stocktwits

Revvity (NYSE:RVTY) Posts Better-Than-Expected Sales In Q1, Full-Year Outlook Slightly Exceeds Expectations

April 28, 2025

Life sciences company Revvity (NYSE:RVTY) announced better-than-expected revenue in Q1 CY2025, with sales up 2.3% year on year to $664.8 million. The company’s full-year revenue guidance of $2.85...

Via StockStory

Revvity Announces Financial Results for the First Quarter of 2025

April 28, 2025

From Revvity

Via Business Wire

Revvity (RVTY) Q1 Earnings Report Preview: What To Look For

April 27, 2025

Life sciences company Revvity (NYSE:RVTY) will be reporting results tomorrow before market hours. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence

Earnings Scheduled For April 28, 2025 ↗

April 28, 2025

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Revvity, Inc. Common Stock (NY:RVTY)

All News about Revvity, Inc. Common Stock

Starting at /week.